Dr Katinka van de Ven
Katinka van de Ven, Ph.D., holds a M.Sc. in Psychology and a M.A. in Criminology from the Utrecht University. Her Ph.D. focused on the production, distribution and use of anabolic-androgenic steroids and other image enhancing drugs in Belgium and the Netherlands. For this research, she received the Research Prize Award from the University of Kent in 2016. She currently works as a Research Fellow at the National Drug and Alcohol Research Centre (NDARC) at the University of New South Wales. In addition, she in collaboration with her colleague Kyle Mulrooney created the Human Enhancement Drug Network (www.humanenhancementdrugs.com). The goal of the network and website is to provide evidence-based information, to share knowledge and experience, to provide harm reduction and human enhancement drug (HED) education, and to collaborate in this growing field of HEDs. Her research interests are in the field of HEDs, drug use and supply, harm reduction, drug policy, anti-doping, health, nutrition and sports. Outside of her academic career, Van de Ven is also highly active in Crossfit, both as a trainer and coach, and bodybuilding, and in her spare time advises clients on nutrition and supplements.
Dr Kyle Mulrooney
Dr. Kyle Mulrooney holds a Ph.D. in Cultural and Global Criminology from the University of Kent and Universität Hamburg, an MA in the Sociology of Law from the International Institute for the Sociology of Law and a BA (Honours) in Criminology and Justice from the University of Ontario Institute of Technology. Kyle is a Lecturer in Criminology at the University of New England. His primary research area is the Sociology of punishment. Kyle’s current research project examines how Canada’s political culture is the cause for the jurisidctions resistance against penal populism, a governing strategy that achieved much politcal success and penal impact elsewhere. Following this research on the politics of punishment, he has taken an interest in the politics and policies surrounding the consumption and regulation of human enhancement drugs. His research in this field aims to explore the use of human enhancement drugs in society and to identify policy strategies which attend to this issue from a socio-cultural and public health perspective. Together with colleagues, Kyle is currently working on an article which asks whether the ‘dark-side’ of steroids has been overstated, as well as an edited collection entitled Human Enhancement Drugs with Routledge due out in 2019.
Anders Schmidt Vinther, MSc.
Anders Schmidt Vinther (MSc in Sport Science) is a PhD student at Department of Public Health at Aarhus University. His project Drug Use and Prevention in Gyms seeks to understand how anabolic steroid use in gyms can be prevented, to what degree it’s possible, and to identify the key barriers in this regard. He has previously been in charge of a Government funded doping prevention programme in one of Denmark’s largest municipalities (the first of its kind in Denmark), and he has several years of practical experience with tobacco, alcohol and drug policy and prevention. With many years of engagement in bodybuilding and power lifting environments, he has an academic as well as a personal interest in the topic of human enhancement.
Dr April Henning
April Henning, Ph.D., is Scholar in Residence at Brooklyn College in the U.S. Her work focuses on the impacts of anti-doping policies on athlete health, with a special interest in amateur sport. Her doctoral work focused on the experience of runners, and has since collaborated on research on cyclists and is working on projects looking at cross-national and cross-sport populations. The National Institute on Drug Abuse (NIDA) supported her post-doctoral work at NDRI. She has received additional research funding from the International Association of Athletics Federations (IAAF) and the World Anti-Doping Agency (WADA). April is a member of USA Cycling’s Committee on Anti-Doping.
Jim McVeigh is Director of the Centre for Public Health (CPH) in the Faculty of Education, Health & Community at Liverpool John Moores University. He is a Reader in Substance Use Epidemiology with research experience encompassing a wide range of drug related issues. However, his main interest remains the use of ‘human enhancement drugs’ in the general population, an area he has worked in since the early 1990s. Prior to his research career he worked as a Registered General Nurse providing healthcare and promoting harm reduction and HIV prevention with injecting drug users. He joined Liverpool John Moores University in 1998 and has built an international reputation in the field of drug use. He has co-authored more than 100 research reports, 50 journal papers, presented at some of the most influential national and international conferences and been invited to contribute to a number of national and international groups and collaborations. Email Jim: email@example.com.
Dr. Matthew Dunn is a Senior Lecturer in Public Health at Deakin University as well as a Conjoint Senior Lecturer at the National Drug and Alcohol Research Centre at UNSW. He is one of the leading researchers investigating the public health aspects of performance and image enhancing drug (PIED) use in Australia. He has worked in the drug and alcohol field for over 10 years. He completed his psychology studies at the University of Wollongong (1997-2000) prior to completing certification in fitness instruction. He undertook a Ph.D. at the University of Sydney (2002-2006), where his dissertation looked at the influence of drug use, exercise, and sexual orientation on body image concerns in men. He worked at the National Drug and Alcohol Research Centre for over five years, working on projects investigating trends in substance use and harm. He led a world-first project investigating illicit substance use issues among elite athletes. He has worked at Deakin University since 2011 and has an active interest in projects which investigate the use of and harms associated with substances to enhance their body or performance. His latest research has investigated how people with ADHD self-manage their symptoms, the use of ‘smart’ and other drugs to enhance academic performance among university students, and health service access among people who use performance and image enhancing drugs. Email Matthew: firstname.lastname@example.org.